do glp-1 lower cholesterol drugs reduce inflammation? Potential of Glucagon-Like Peptide 1

No bacterial growth concerns

In summary, our study advances the understanding of the molecular mechanisms underlying intestinal maturation, highlighting CFTRs critical role and the therapeutic potential of targeting CFTR alongside the FGF2 and TGF1 signaling axis

Weight-loss outcomes depend on starting weight, dose, adherence, diet, physical activity, medical history, and individual biology

Back Nair, P (2024) 'QnAs with Svetlana Mojsov, Joel Habener, and Lotte Bjerre Knudsen: Winners of the 2024 Lasker~DeBakey Clinical Medical Research Award', Proceedings of the National Academy of Sciences , 121/39, e2416868121